Bryan, Garnier & Co's News

Read all the news of the independent investment banking dedicated to Growth

Novartis: Sandoz ready to compete for Enbrel's US market

BUY, Fair Value CHF110 (+23%)

Published last October Friday 2, 2015

Bayer: FV reduced after adjustment to Covestro listing

NEUTRAL vs. BUY, Fair Value EUR124 vs. EUR135 (+10%)

Published last October Friday 2, 2015

Bayer: Covestro - Terms of listing changed

BUY, Fair Value UNDER REVIEW

Published last October Thursday 1, 2015

Galapagos: What deal should we be looking for now?

BUY, Fair Value EUR52 vs. EUR50 (+42%)

Published last October Thursday 1, 2015

TOP PICKS Q4 2015 : Good Buy SABMiller

Published last October Thursday 1, 2015

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities